Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amrendra Kumar

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Journal for Immunotherapy of Cancer|May 25, 2023
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responsesAmrendra Kumar, Vijay Ramani, Vijaya Bharti, et al.
Molecules (Basel, Switzerland)|December 23, 2023
Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial AntibioticsMousumi Shyam, Gourab Bhattacharje, Chris Daniel, et al.
Journal of Viral Hepatitis|January 3, 2023
DDX3-mediated miR-34 expression inhibits autophagy and HBV replication in hepatic cellsAmit Kumar Mishra, Md Musa Hossain, Mohd Umar, et al.
Gastroenterology Research|May 1, 2018
Direct-Acting Antivirals in Chronic Hepatitis C Genotype 4 Infection in Community Care SettingVijay Gayam, Mazin Khalid, Amrendra Kumar Mandal, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2021
Mitochondrial metabolism is essential for invariant natural killer T cell development and functionXiufang Weng, Amrendra Kumar, Liang Cao, et al.
Nanomedicine (London, England)|September 3, 2024
LC-MS/MS method for simultaneous Doxorubicin and Baicalein estimation: formulation and pharmacokinetic applicationsPooja Yadav, Sanjay Singh, Divya Chauhan, et al.
BMC Infectious Diseases|January 4, 2026
Circular RNA SETD2 (circSETD2) elevates DDX3 expression to inhibit autophagy in hepatitis B virus infection via targeting miR-181a-5pMd Ismail, Teja Naveen Sata, Md Fahim Khalid, et al.
JCI Insight|June 20, 2024
TTK inhibitor OSU13 promotes immunotherapy responses by activating tumor STINGVijaya Bharti, Amrendra Kumar, Yinchong Wang, et al.
Cell Death and Differentiation|March 20, 2025
Cryo-EM structure of the brine shrimp mitochondrial ATP synthase suggests an inactivation mechanism for the ATP synthase leak channelAmrendra Kumar, Juliana da Fonseca Rezende E Mello, Yangyu Wu, et al.
Virus Genes|February 11, 2025
ALR inhibits HBV replication and autophagosome formation by ameliorating HBV-induced ROS production in hepatic cellsAmit Kumar Mishra, Md Musa Hossain, Teja Naveen Sata, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Journal for Immunotherapy of Cancer|May 25, 2023
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responsesAmrendra Kumar, Vijay Ramani, Vijaya Bharti, et al.
Molecules (Basel, Switzerland)|December 23, 2023
Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial AntibioticsMousumi Shyam, Gourab Bhattacharje, Chris Daniel, et al.
Journal of Viral Hepatitis|January 3, 2023
DDX3-mediated miR-34 expression inhibits autophagy and HBV replication in hepatic cellsAmit Kumar Mishra, Md Musa Hossain, Mohd Umar, et al.
Gastroenterology Research|May 1, 2018
Direct-Acting Antivirals in Chronic Hepatitis C Genotype 4 Infection in Community Care SettingVijay Gayam, Mazin Khalid, Amrendra Kumar Mandal, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2021
Mitochondrial metabolism is essential for invariant natural killer T cell development and functionXiufang Weng, Amrendra Kumar, Liang Cao, et al.
Nanomedicine (London, England)|September 3, 2024
LC-MS/MS method for simultaneous Doxorubicin and Baicalein estimation: formulation and pharmacokinetic applicationsPooja Yadav, Sanjay Singh, Divya Chauhan, et al.
BMC Infectious Diseases|January 4, 2026
Circular RNA SETD2 (circSETD2) elevates DDX3 expression to inhibit autophagy in hepatitis B virus infection via targeting miR-181a-5pMd Ismail, Teja Naveen Sata, Md Fahim Khalid, et al.
JCI Insight|June 20, 2024
TTK inhibitor OSU13 promotes immunotherapy responses by activating tumor STINGVijaya Bharti, Amrendra Kumar, Yinchong Wang, et al.
Cell Death and Differentiation|March 20, 2025
Cryo-EM structure of the brine shrimp mitochondrial ATP synthase suggests an inactivation mechanism for the ATP synthase leak channelAmrendra Kumar, Juliana da Fonseca Rezende E Mello, Yangyu Wu, et al.
Virus Genes|February 11, 2025
ALR inhibits HBV replication and autophagosome formation by ameliorating HBV-induced ROS production in hepatic cellsAmit Kumar Mishra, Md Musa Hossain, Teja Naveen Sata, et al.
Pageof 15